6609.HK

Shanghai HeartCare Medical Technology Corporation Limited [6609.HK] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

6609.HK Stock Summary

Top 10 Correlated ETFs

6609.HK

Top 10 Correlated Stocks

6609.HK

In the News

6609.HK Financial details

Company Rating
-
Market Cap
679.59M
Income
-121.12M
Revenue
162.75M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
368
Optionable
No
Shortable
Yes
Earnings
28 Aug 2024
P/E
-4.39
Forward P/E
-
PEG
0.95
P/S
4.89
P/B
0.76
P/C
-
P/FCF
-2.94
Quick Ratio
12.89
Current Ratio
16.77
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-3.16
EPS next Y
-
EPS next Q
-
EPS this Y
-10.58%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-12.09%
SMA50
0.99%
SMA100
25.65%
Inst Own
-
Inst Trans
-
ROA
-15%
ROE
-16%
ROC
-0.16%
Gross Margin
68%
Oper. Margin
-108%
Profit Margin
-109%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
15.64-43.0
52W High
-31.51%
52W Low
+96.33%
RSI
56.21
Rel Volume
0.3
Avg Volume
75.1K
Volume
22.5K
Perf Week
11.34%
Perf Month
-8.54%
Perf Quarter
47.4%
Perf Half Y
47.4%
-
-
-
-
Beta
0.741
-
-
Volatility
0.8%, 2.14%
Prev Close
9.89%
Price
29.45
Change
16.4%

Something similar

Top by Market Cap
VTSAX
AAPL
BRK-A
BRH.DE
GOOG
Top Correlated ETFs
EZNC.MI
ONEQ.TO
IWML
BRIC.SW
RUBY.TO
Top Correlated Stocks
ELK.OL
1402.HK
NHY.OL
LSG.OL
0QKB.L
Similar Market Cap
METV
BCYP
AORT
BOWL.L
INVA

Company Profile

Healthcare Medical - Devices
  • Volume Average 75.1K
  • Market Capitalization 679.59M
  • Employee 368
  • CEO Mr. Guohui Wang
  • Headquarters Shanghai,CN
  • IPO Date 2021-08-20
  • Website https://www.heartcare.com.cn

Shanghai HeartCare Medical Technology Corporation Limited engages in the research, development, manufacture, and sale of neuro-interventional medical devices worldwide. The company offers ischemic stroke thrombectomy, intracranial stenosis treatment, ischemic stroke prevention, hemorrhagic stroke treatment, and vascular access devices. Its products are used for the treatment and prevention of ischemic stroke, including acute ischemic stroke and intracranial stenosis, as well as for the treatment of hemorrhagic stroke. The company was formerly known as Shanghai Care Medical Technology Corporation Limited. Shanghai HeartCare Medical Technology Corporation Limited was incorporated in 2016 and is headquartered in Shanghai, the People's Republic of China.